HSHeejong Sung

Heejong Sung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Heejong Sung has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    528. Heritability of Mood Disorder Questionnaire Scores in Families Affected by Bipolar Disorder

    by Alejandro Arbona-Lampaya, Heejong Sung, Emily Besançon, Alexander D'Amico, Ally Freifeld, Ley Lacbawan, Emma Knowles, Fabiana Lopes, Layla Kassem, Antonio Nardi, et al.

  • 413. Heritability of Cognitive Functioning in Patients With Bipolar Disorder and Their Unaffected Relatives

    by Alexander D'Amico, Heejong Sung, Emily Besançon, Alejandro Arbona-Lampaya, Ally Freifeld, Ley Lacbawan, Emma Knowles, Layla Kassem, Francis J. McMahon

  • Open Access

    Cover

    by Heejong Sung, Paula L. Hyland, Alexander Pemov, Jeremy A. Sabourin, Andrea M. Baldwin, Sara Bass, Kedest Teshome, Wen Luo, Frederick National Laboratory for Cancer Research, Brigitte C. Widemann, et al.

  • Open Access

    Genome‐wide association study of café‐au‐lait macule number in neurofibromatosis type 1

    by Heejong Sung, Paula L. Hyland, Alexander Pemov, Jeremy A. Sabourin, Andrea M. Baldwin, Sara Bass, Kedest Teshome, Wen Luo, Brigitte C. Widemann, Douglas R. Stewart, et al.

    Background: Neurofibromatosis type 1 (NF1) is a tumor‐predisposition disorder that arises due to pathogenic variants in tumor suppressor NF1. NF1 has variable expressivity that may be due, at least in part, from heritable elements such as modifier genes; however, few genetic modifiers have been identified to date.Methods: In this study, we performed a genome‐wide association analysis of the number of café‐au‐lait macules (CALM) that are considered a tumor‐like trait as a clinical phenotype modifying NF1.Results: A borderline genome‐wide significant association was identified in the discovery cohort (CALM1, N = 112) between CALM number and rs12190451 (and rs3799603, r2 = 1.0; p = 7.4 × 10−8) in the intronic region of RPS6KA2. Although, this association was not replicated in the second cohort (CALM2, N = 59) and a meta‐analysis did not show significantly associated variants in this region, a significant corroboration score (0.72) was obtained for the RPS6KA2 signal in the discovery cohort (CALM1) using Complementary Pairs Stability Selection for Genome‐Wide Association Studies (ComPaSS‐GWAS) analysis, suggesting that the lack of replication may be due to heterogeneity of the cohorts rather than type I error.Conclusion: rs12190451 is located in a melanocyte‐specific enhancer and may influence RPS6KA2 expression in melanocytes—warranting further functional studies.


  • ComPaSS‐GWAS: A method to reduce type I error in genome‐wide association studies when replication data are not available

    by Jeremy A. Sabourin, Cheryl D. Cropp, Heejong Sung, Lawrence C. Brody, Joan E. Bailey‐Wilson, Alexander F. Wilson

    Results from association studies are traditionally corroborated by replicating the findings in an independent data set. Although replication studies may be comparable for the main trait or phenotype of interest, it is unlikely that secondary phenotypes will be comparable across studies, making replication problematic. Alternatively, there may simply not be a replication sample available because of the nature or frequency of the phenotype. In these situations, an approach based on complementary pairs stability selection for genome‐wide association study (ComPaSS‐GWAS), is proposed as an ad‐hoc alternative to replication. In this method, the sample is randomly split into two conditionally independent halves multiple times (resamples) and a GWAS is performed on each half in each resample. Similar in spirit to testing for association with independent discovery and replication samples, a marker is corroborated if its p‐value is significant in both halves of the resample. Simulation experiments were performed for both nongenetic and genetic models. The type I error rate and power of ComPaSS‐GWAS were determined and compared to the statistical properties of a traditional GWAS. Simulation results show that the type I error rate decreased as the number of resamples increased with only a small reduction in power and that these results were comparable with those from a traditional GWAS. Blood levels of vitamin pyridoxal 5′‐phosphate from the Trinity Student Study (TSS) were used to validate this approach. The results from the validation study were compared to, and were consistent with, those obtained from previously published independent replication data and functional studies.


  • Open Access

    Evaluation of random forests performance for genome-wide association studies in the presence of interaction effects

    by Yoonhee Kim, Robert Wojciechowski, Heejong Sung, Rasika A Mathias, Li Wang, Alison P Klein, Rhoshel K Lenroot, James Malley, Joan E Bailey-Wilson

    Random forests (RF) is one of a broad class of machine learning methods that are able to deal with large-scale data without model specification, which makes it an attractive method for genome-wide association studies (GWAS). The performance of RF and other association methods in the presence of interactions was evaluated using the simulated data from Genetic Analysis Workshop 16 Problem 3, with knowledge of the major causative markers, risk factors, and their interactions in the simulated traits. There was good power to detect the environmental risk factors using RF, trend tests, or regression analyses but the power to detect the effects of the causal markers was poor for all methods. The causal marker that had an interactive effect with smoking did show moderate evidence of association in the RF and regression analyses, suggesting that RF may perform well at detecting such interactions in larger, more highly powered datasets.